(19)
(11) EP 1 883 446 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.11.2017 Bulletin 2017/46

(45) Mention of the grant of the patent:
06.09.2017 Bulletin 2017/36

(21) Application number: 06722946.8

(22) Date of filing: 15.05.2006
(51) International Patent Classification (IPC): 
A61M 31/00(2006.01)
A61F 2/00(2006.01)
 A61K 9/00(2006.01)
(86) International application number:
PCT/DK2006/000261
(87) International publication number:
WO 2006/122551 (23.11.2006 Gazette 2006/47)

(54)

AN IMPLANTABLE THERAPY SYSTEM FOR TREATING A LIVING BEING WITH AN ACTIVE FACTOR

IMPLANTIERBARES THERAPIESYSTEM ZUR BEHANDLUNG EINES LEBEWESENS MIT EINEM WIRKFAKTOR

SYSTEME DE THERAPIE IMPLANTABLE POUR TRAITER UN ETRE VIVANT AVEC UN FACTEUR ACTIF

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK YU

(30) Priority: 17.05.2005 DK 200500723
25.11.2005 DK 200501668

(43) Date of publication of application:
06.02.2008 Bulletin 2008/06

(73) Proprietor: Gloriana Therapeutics Sarl
1202 Genève (CH)

(72) Inventors:
  • TORNØE, Jens
    DK-2100 Copenhagen Ø (DK)
  • WAHLBERG, Lars, U.
    DK-4550 Asnæs (DK)

(74) Representative: Høiberg P/S 
Adelgade 12
1304 Copenhagen K
1304 Copenhagen K (DK)


(56) References cited: : 
US-A- 5 773 286
US-A- 5 874 099
US-B1- 6 179 826
 US-A- 5 786 216
US-A- 6 123 700
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).